- Natera Portal Hub
Visit the appropriate Natera™ portal to check on results, schedule conversations with genetic counselors, place orders, or make payments
- Natera - Unified patient portal
Log in to Natera’s Patient PortalContinue with Google
- Natera - Wikipedia
Natera, Inc is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health
- Natera Announces Broad Clinical Launch of Ultra-Sensitive . . .
Extensive pan-cancer validation data from over 3,000 plasma samples to be presented at ASCO Natera, Inc (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its ultra-sensitive Signatera Genome assay is now broadly available to physicians in the United States
- Natera CEO on cancer recurrence detection and how it works
Steve Chapman, Natera CEO, joins 'Squawk Box' to discuss the company's innovative technique, how cancer recurrence detection works and much more
- Natera: A global leader in cell-free DNA testing
Dedicated to oncology, women’s health, and organ health Natera’s cell-free DNA tests help protect health and inform more personalized decisions about care
- Natera Presents Data at ESMO GI on its Tissue-Free Latitude . . .
Natera, Inc (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced data from a colorectal cancer (CRC) study of its tissue
|